We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.31% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Employers Holdings
EIG
$935M
| $2.29M | ﹤0.01% |
48,542
+703
| +1% | +$33.9K |
|
902
Upbound Group
UPBD
$1.23B
| $2.29M | ﹤0.01% |
91,234
-210,857
| -70% | -$4.93M |
|
903
Kyndryl
KD
$2.72B
| $2.29M | ﹤0.01% |
54,571
+6,241
| +13% | +$226K |
|
904
Zymeworks
ZYME
$1.83B
| $2.29M | ﹤0.01% |
182,270
+358
| +0.2% | +$4.26K |
|
905
Peoples Bancorp
PEBO
$1.38B
| $2.29M | ﹤0.01% |
74,901
+2,353
| +3% | +$68.7K |
|
906
Constellation Energy
CEG
$92B
| $2.29M | ﹤0.01% |
7,085
+2,714
| +62% | +$718K |
|
907
Markel Group
MKL
$24.6B
| $2.28M | ﹤0.01% |
1,142
-362
| -24% | -$679K |
|
908
Enpro
NPO
$6.89B
| $2.27M | ﹤0.01% |
11,868
-444
| -4% | -$75.9K |
|
|
SAGE
909
DELISTED
Sage Therapeutics
SAGE
| $2.25M | ﹤0.01% |
246,804
-945,685
| -79% | -$6.96M |
|
910
Vanguard Total Stock Market ETF
VTI
$663B
| $2.25M | ﹤0.01% |
7,403
| – | – |
|
911
Mueller Industries
MLI
$12.5B
| $2.25M | ﹤0.01% |
56,620
-1,078
| -2% | -$40.7K |
|
912
Akebia Therapeutics
AKBA
$370M
| $2.25M | ﹤0.01% |
617,318
-296,131
| -32% | -$814K |
|
913
Macerich
MAC
$7.02B
| $2.24M | ﹤0.01% |
138,222
-263,059
| -66% | -$4.06M |
|
|
FITB
914
Fifth Third Bancorp
FITB
$51.8B
| $2.23M | ﹤0.01% |
54,273
-9,406
| -15% | -$353K |
|
915
Tarsus Pharmaceuticals
TARS
$2.59B
| $2.23M | ﹤0.01% |
55,021
+339
| +0.6% | +$15.3K |
|
916
CareDx
CDNA
$1.49B
| $2.23M | ﹤0.01% |
113,950
-17,911
| -14% | -$318K |
|
917
Manhattan Associates
MANH
$9.37B
| $2.21M | ﹤0.01% |
11,203
+1,024
| +10% | +$186K |
|
918
InMode
INMD
$871M
| $2.2M | ﹤0.01% |
152,233
-197
| -0.1% | -$2.89K |
|
919
NovoCure
NVCR
$1.86B
| $2.19M | ﹤0.01% |
123,072
-97,003
| -44% | -$1.69M |
|
|
BLD
920
DELISTED
TopBuild
BLD
| $2.19M | ﹤0.01% |
6,759
+654
| +11% | +$194K |
|
921
Antero Resources
AR
$10.6B
| $2.18M | ﹤0.01% |
54,020
-3,652
| -6% | -$138K |
|
922
ePlus
PLUS
$2.35B
| $2.14M | ﹤0.01% |
+29,719
| New | +$1.95M |
|
923
Kemper
KMPR
$1.76B
| $2.14M | ﹤0.01% |
33,170
+27,482
| +483% | +$1.7M |
|
924
Valaris
VAL
$5.51B
| $2.13M | ﹤0.01% |
50,609
+47,663
| +1,618% | +$1.79M |
|
925
Codexis
CDXS
$205M
| $2.13M | ﹤0.01% |
872,814
-215,137
| -20% | -$505K |
|
Similar funds
